Mirati Therapeutics (NASDAQ:MRTX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Mirati Therapeutics beat estimated earnings by 10.42%, reporting an EPS of $-3.18 versus an estimate of $-3.55.
Revenue was up $6.46 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 1.96% drop in the share price the next day.
Here’s a look at Mirati Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -3.55 | -3.48 | -3.49 | -3.49 |
| EPS Actual | -3.51 | -3.09 | -3.18 | -3.40 |
| Revenue Estimate | 2.27M | 1.26M | 340K | 160K |
| Revenue Actual | 934K | 5.43M | 5.36M | 709K |
To track all earnings releases for Mirati Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
